USPTO serial 79229688
CENTODX
Reviewed by CopyMark Law Group
Reg. 5742095Status 709
- Filing date
- Status date
- Registration date
- May 7, 2019
- Examiner
- VO, JULIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CENTODX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
Angela P. Doughty WARD AND SMITH, P.A.751 Corporate Center Drive Suite 300Post Office Box 33009Raleigh, NC 27636-3009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for hereditary diseases, metabolic diseases, oncological diseases, and complex multigenic diseases and veterinary preparations for hereditary diseases, metabolic diseases, oncological diseases, and complex multigenic diseases; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, for medical and veterinary purposes, namely for detecting genetic predispositions; biological preparations for medical purposes for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases; cultures of microorganisms for medical or veterinary use | SECTION 71 - CANCELLED | — |
| 009 | Scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; pre-recorded compact discs, DVDs and downloadable audio and video recordings featuring clinical phenotypic, genetic molecular and demographic information; computers; computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments | SECTION 71 - CANCELLED | — |
| 035 | Database management, namely, collating and systematic ordering of data in a computer database; computerized file management | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely genetic and biochemical analytical testing for scientific research purposes in the field of hereditary diseases, oncology, and complex genetics related diseases and research and design relating thereto in the field of computer hardware and computer software that support the processing and analysis of complex genomic data; industrial analysis and research services in the field of genetics and in the field of pharmaceutical development; scientific research for medical purposes; providing of information in the fields of pharmacology; design and development of computer hardware and software; medical laboratory services | SECTION 71 - CANCELLED | — |
| 044 | Medical services, namely medical analysis in connection with the treatment of individuals; providing of information in the fields of medicine and veterinary medicine; health centers; medical clinics; therapy services, namely, mental health therapy services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Centogene AG
- Other trademarks owned by Centogene AG
- Other trademarks owned by Centogene GmbH
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CENTODX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 21, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 21, 2025 | C71T | CANCELLED SECTION 71 | — |
| May 7, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 18, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 20, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 3, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 3, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 13, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 7, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 7, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 19, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 15, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 30, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 30, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 30, 2019 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 10, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 16, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 16, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 16, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jun 8, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 19, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 19, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 17, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 10, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 6, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 5, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |